|
Volumn 270, Issue 4, 2013, Pages 1195-1202
|
The evolving role of selective neck dissection for head and neck squamous cell carcinoma.
a a a a a a a a a a
a
not available
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
HEAD AND NECK TUMOR;
HUMAN;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
METHODOLOGY;
MINIMAL RESIDUAL DISEASE;
NECK DISSECTION;
PATHOLOGY;
REVIEW;
RISK;
SALVAGE THERAPY;
SQUAMOUS CELL CARCINOMA;
TREATMENT OUTCOME;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
NECK DISSECTION;
NEOPLASM, RESIDUAL;
OTORHINOLARYNGOLOGIC NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
RISK;
SALVAGE THERAPY;
TREATMENT OUTCOME;
|
EID: 85027953434
PISSN: None
EISSN: 14344726
Source Type: None
DOI: 10.1007/s00405-012-2153-x Document Type: Review |
Times cited : (37)
|
References (0)
|